The ADCmean of 1.2 can be used as an optimal cutoff value to differentiate IDH wild-type and IDH-mutant gliomas irrespective of WHO grade and tumors with ADCmean less than 1.08 had poor survival [46]. The gene discussed is IDH1; the disease is central nervous system cancer.